Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII

Haematologica

Volumn 95, Issue 11, 2010, Pages 1927-1934

  Nadir, Yona ^a   Brenner, Benjamin ^a   Fux, Liat ^a   Shafat, Itay ^a   Attias, Judith ^a   Vlodavsky, Israel ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Coagulation cascade; Heparanase; Tissue factor; Xa level

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; HEPARANASE; HEPARIN; PLACENTA PROTEIN 5; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CELL CULTURE; CELL STRAIN HEK293; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME BLOOD LEVEL; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; FACTOR VIIA; FACTOR XA; FEMALE; GLUCURONIDASE; GLYCOPROTEINS; HEK293 CELLS; HEPARIN; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SERINE PROTEINASE INHIBITORS; THROMBOPLASTIN;

EID: 78149241704     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.023713     Document Type: Article

References (33)

1. Freeman C, Parish CR. Human platelet heparanase: purification, characterization and catalytic activity. Biochem J. 1998;330 (Pt 3):1341-50.
2. Pikas DS, Li JP, Vlodavsky I, Lindahl U. Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem. 1998;273(30):18770-7.
3. Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta. 2001; 1471(3):M99-108.
4. Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest. 2001;108(3):341-7.
5. Goldshmidt O, Zcharia E, Aingorn H, Guatta-Rangini Z, Atzmon R, Michal I, et al. Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence. J Biol Chem. 2001;276(31):29178-87.
6. Dempsey LA, Brunn GJ, Platt JL. Heparanase, a potential regulator of cellmatrix interactions. Trends Biochem Sci. 2000;25(8):349-51.
7. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med. 1999;5(7):803-9.
8. Kussie PH, Hulmes JD, Ludwig DL, Patel S, Navarro EC, Seddon AP, et al. Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun. 1999;261(1):183-7.
9. Toyoshima M, Nakajima M. Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem. 1999;274(34):24153-60.
10. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med. 1999;5(7): 793-802.
11. Goldshmidt O, Zcharia E, Cohen M, Aingorn H, Cohen I, Nadav L, et al. Heparanase mediates cell adhesion independent of its enzymatic activity. Faseb J. 2003;17(9):1015-25.
12. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N. Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem. 2004;279 (22):23536-41.
13. Zetser A, Bashenko Y, Edovitsky E, Levy- Adam F, Vlodavsky I, Ilan N. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res. 2006;66(3):1455-63.
14. Nadir Y, Brenner B, Zetser A, Ilan N, Shafat I, Zcharia E, et al. Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J Thromb Haemost. 2006;4(11):2443-51.
15. Nadir Y, Brenner B, Gingis-Velitski S, Levy- Adam F, Ilan N, Zcharia E, et al. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Thromb Haemost. 2008;99(1):133-41.
16. Gingis-Velitski S, Zetser A, Kaplan V, Ben- Zaken O, Cohen E, Levy-Adam F, et al. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J Biol Chem. 2004;279(42):44084-92.
17. Zetser A, Bashenko Y, Miao HQ, Vlodavsky I, Ilan N. Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res. 2003; 63(22):7733-41.
18. Zetser A, Levy-Adam F, Kaplan V, Gingis- Velitski S, Bashenko Y, Schubert S, et al. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci. 2004;117(Pt 11):2249-58.
19. Nardella C, Lahm A, Pallaoro M, Brunetti M, Vannini A, Steinkühler C. Mechanism of activation of human heparanase investigated by protein engineering. Biochemistry. 2004;43(7):1862-73.
20. Hulett MD, Hornby JR, Ohms SJ, Zuegg J, Freeman C, Gready JE, Parish CR. Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry. 2000;39(51): 15659-67.
21. Shafat I, Zcharia E, Nisman B, Nadir Y, Nakhoul F, Vlodavsky I, Ilan N. An ELISA method for the detection and quantification of human heparanase. Biochem Biophys Res Commun. 2006;341(4):958-63.
22. Shafat I, Barak AB, Postovsky S, Elhasid R, Ilan N, Vlodavsky I, Arush MW. Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment. Neoplasia. 2007;9(11):909-16.
23. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, et al. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J. 1997;134(2 Pt 1):253-9.
24. Kim HK, Song KS, Park YS, Yun YS, Shim WH. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease. Cardiology. 2000;93(1-2):31-6.
25. Udagawa K, Yasumitsu H, Esaki M, Sawada H, Nagashima Y, Aoki I, et al. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anticoagulant on the surface of syncytiotrophoblasts. Placenta. 2002;23(2-3):145-53.
26. Mandal SK, Pendurthi UR, Rao LV. Cellular localization and trafficking of tissue factor. Blood. 2006;107(12):4746-53.
27. Ben-Zaken O, Gingis-Velitski S, Vlodavsky I, Ilan N. Heparanase induces Akt phosphorylation via a lipid raft receptor. Biochem Biophys Res Commun. 2007;361(4):829-34.
28. Steffel J, Akhmedov A, Greutert H, Lüscher TF, Tanner FC. Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation. 2005; 112(3):341-9.
29. Camera M, Giesen PL, Fallon J, Aufiero BM, Taubman M, Tremoli E, Nemerson Y. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19(3):531-7.
30. Schecter AD, Giesen PL, Taby O, Rosenfield CL, Rossikhina M, Fyfe BS, et al. Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest. 1997;100(9):2276-85.
31. Wolberg AS, Monroe DM, Roberts HR, Hoffman MR. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserinedependent and -independent mechanisms. Blood Coagul Fibrinolysis. 1999;10(4):201-10.
32. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis. 1992;12(2):112-27.
33. Shafat I, Vlodavsky I, Ilan N. Characterization of mechanisms involved in secretion of active heparanase. J Biol Chem. 2006;281(33): 23804-11.